Insulet expects to incur up to $40 million in costs associated with the correction in 2026 and does not anticipate updating its previously issued guidance for the year, according to a filing with the ...
Earlier this week, Insulet announced a voluntary medical device correction and recall for specific Omnipod 5 pod lots in the US after detecting a manufacturing defect that can cause insulin ...
Billerica, Massachusetts-based Insulet Corporation, maker of the OmniPod Insulin pump, has just announced that it received the FDA clearance to commercialize its latest product the Omnipod Dash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results